• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Intensive Care Med . Predictive Value of Eosinophil Count on COVID-19 Disease Progression and Outcomes, a Retrospective Study of Leishenshan Hosp

tetano

Editor, Senior Moderator
J Intensive Care Med


. 2021 Sep 22;8850666211037326.
doi: 10.1177/08850666211037326. Online ahead of print.
Predictive Value of Eosinophil Count on COVID-19 Disease Progression and Outcomes, a Retrospective Study of Leishenshan Hospital in Wuhan, China


Wei Xuan[SUP] 1 [/SUP], Xuliang Jiang[SUP] 1 [/SUP], Lili Huang[SUP] 1 [/SUP], Shuting Pan[SUP] 2 [/SUP], Caiyang Chen[SUP] 1 [/SUP], Xiao Zhang[SUP] 1 [/SUP], Hui Zhu[SUP] 1 [/SUP], Song Zhang[SUP] 1 [/SUP], Weifeng Yu[SUP] 1 [/SUP], Zhiyong Peng[SUP] 3 [/SUP], Diansan Su[SUP] 1 [/SUP]



Affiliations

Abstract

Background: The potential protective role of eosinophils in the COVID-19 pandemic has aroused great interest, given their potential virus clearance function and the infection resistance of asthma patients to this coronavirus. However, it is unknown whether eosinophil counts could serve as a predictor of the severity of COVID-19.
Methods: A total of 1004 patients with confirmed COVID-19 who were admitted to Leishenshan Hospital in Wuhan, China, were enrolled in this study, including 905 patients in the general ward and 99 patients in the intensive care unit (ICU). We reviewed their medical data to analyze the association between eosinophils and ICU admission and death.
Results: Of our 1004 patients with COVID-19, low eosinophil counts/ratios were observed in severe cases. After adjusting for confounders that could have affected the outcome, we found that eosinophil counts might not be a predictor of ICU admission. In 99 ICU patients, 58 of whom survived and 41 of whom died, low eosinophil level was an indicator of death in severe COVID-19 patients with a cutoff value of 0.04 × 10[SUP]9[/SUP]/L, which had an area under the curve of 0.665 (95% CI = 1.089-17.839; P = .045) with sensitivity and specificity of 0.569 and 0.7317, respectively.
Conclusion: Our research revealed that a low eosinophil level is a predictor of death in ICU patients rather than a cause of ICU admission.

Keywords: COVID-19; asthma; coronavirus; eosinophil; leukocyte.
 
Back
Top Bottom